
Rep. Glenn Grothman @RepGrothman
Studies from Hebrew University in Jerusalem and Mt. Sinai Hospital in NY show that the already FDA-approved Fenofibrate, brand name Tricor, could help downgrade the severity of #COVID19. From the House floor, I called on @CDCGov & @NIH to pursue this potentially life-saving lead. https://t.co/uKlpGJyFOu — PolitiTweet.org